VRDN- Viridian Therapeutics, Inc.\de
Viridian Therapeutics, Inc.\de (VRDN) has 2 insiders with recent SEC Form 4 filings, including 7 buys and 6 sells. VRDN is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 3.91M | $88.11M | - | |
| Other | 0 | - | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Tousignant Jennifer | Chief Legal Officer | Sell | 2,272 | $31.16 | $70,795.52 | -100% | -37.1% | - | |
| Oct 23, 2025 | Fairmount Funds Management LLC74 | Director, 10% Owner | Buy | 454,545 | $22.00 | $9,999,990.00 | +13.1% | +46.3% | - | |
| Sep 27, 2024 | Beetham Thomas W. | Chief Operating Officer | Buy | 5,000 | $23.41 | $117,050.00 | +500.0% | -15.0% | -13.5% | |
| Sep 27, 2024 | Mahoney Stephen F. | President And CEO | Buy | 21,400 | $23.33 | $499,262.00 | New | -15.0% | -13.5% | |
| Sep 13, 2024 | Fairmount Funds Management LLC74 | Director, 10% Owner | Buy | 1,600,000 | $18.75 | $30,000,000.00 | +86.7% | -18.4% | -14.5% | |
| Jan 22, 2024 | Fairmount Funds Management LLC74 | Director, 10% Owner, See Remarks | Buy | 476,190 | $21.00 | $9,999,990.00 | +34.9% | -28.5% | -7.9% | |
| Jun 16, 2023 | Meisner Lara71 | Chief Legal Officer | Sale+OE | 2,296 | $28.02 | $64,342.83 | -3.7% | -35.4% | -54.1% | |
| Jun 6, 2023 | Meisner Lara71 | Chief Legal Officer | Sale+OE | 7,500 | $24.82 | $186,136.24 | -7.7% | -22.6% | -50.6% | |
| Apr 12, 2023 | Myers Scott Dunseth47 | Chief Executive Officer | Buy | 4,000 | $25.37 | $101,478.80 | +1.6% | -18.1% | -35.3% | |
| Mar 13, 2023 | Myers Scott Dunseth47 | Chief Executive Officer | Buy | 5,500 | $29.15 | $160,324.45 | +2.2% | -11.6% | -39.0% |
Page 1Next →